Nippon India Pharma Fund vs Quant Healthcare Fund Regular compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Quant Healthcare Fund Regular - Growth
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8689 Cr | ₹437 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹1000 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 17 Jun 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare TRI |
| Turn Over | 21% | % |
| Expense Ratio | 1.81 | 2.38 |
| Manager | Sailesh Raj Bhan | Sanjeev Sharma |
| ISIN Code | INF204K01968 | INF966L01CG3 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Month | 3.03% | -2.83% |
| 6 Month | 13.37% | 3.53% |
| 1 Year | 36.31% | 31.17% |
| 3 Year | 20.52% | - |
| 5 Year | 27.7% | - |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 26.5% | 12.42% |
| 3 Year | 30.42% | - |
| 5 Year | 25.06% | - |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Year | 17.79% | 59.34% |
| 3 Year | 20.87% | - |
| 5 Year | 20.18% | - |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Standard Deviation | 14.36% | - |
| Sharp | 0.68% | - |
| Beta | 0.91% | - |
| Alpha | 1.57% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Sanjeev Sharma |
| Total AUM | ₹96086 Cr | ₹39731 Cr |
| Fund Manage | 5 | 22 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 4.4 | 5.19 |
| Large Cap | 45.96 | 15.52 |
| Mid Cap | 27.12 | 18.76 |
| Small Cap | 22.52 | 60.53 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 4.4 | 5.19 |
| Pharmaceuticals & Biotechnology | 75.86 | 64.82 |
| Healthcare Services | 17.38 | 9.02 |
| Retailing | 2.36 | - |
| Petroleum Products | - | 7.46 |
| Telecom - Services | - | 7.82 |
| Food Products | - | 5.69 |
Top Comparisons
Tata Overnight Fund-Regular Plan-Growth
3Y Returns5.88%
Quant Overnight Fund Regular - Growth
3Y Returns0%
Tata Hybrid Equity Fund- Regular Plan - Growth Option
3Y Returns12.87%
Mirae Asset Aggressive Hybrid Fund -Regular Plan-Growth
3Y Returns11.92%
Nippon India Consumption Fund-Growth Plan-Growth Option
3Y Returns20.31%
Canara Robeco Consumer Trends Fund - Regular Plan - Growth Option
3Y Returns17.93%
Nippon India Corporate Bond Fund - Growth Plan - Growth Option
3Y Returns6.55%
UTI Corporate Bond Fund - Regular Plan - Growth Option
3Y Returns5.93%